Hassouneh Z, Noel ODV, Ji N, Kim ME, Svatek J, Svatek RS, Risinger AL, Mukherjee N.
Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer. Cancers. 2024; 16(22):3875.
https://doi.org/10.3390/cancers16223875

Chicago/Turabian Style

Hassouneh, Zaineb, Onika D. V. Noel, Niannian Ji, Michelle E. Kim, Jordan Svatek, Robert S. Svatek, April L. Risinger, and Neelam Mukherjee.
2024. “Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer” Cancers 16, no. 22: 3875.
https://doi.org/10.3390/cancers16223875

APA Style

Hassouneh, Z., Noel, O. D. V., Ji, N., Kim, M. E., Svatek, J., Svatek, R. S., Risinger, A. L., & Mukherjee, N.

(2024). Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer. Cancers, 16(22), 3875.
https://doi.org/10.3390/cancers16223875